Chest:有偿服务医疗保险受益人的肺癌筛查利用率

2019-11-29 xiangting MedSci原创

研究发现自医疗保险开始实施报销政策以来,LCS利用率呈稳定增长。

肺癌筛查LCS)是降低肺癌死亡率的重要二级预防措施。这项研究旨在评估自2015年医疗保险开始实施LCS报销政策以来的3年内,美国老年人LCS的州级差异。

这项生态研究使用Kruskal-Wallis检验和聚类分析,分析了LCS利用密度与每1000名有偿服务(FFS)医疗保险受益人共享决策和咨询(SDMC)之间的关联,LCS利用率定义为低剂量计算机断层扫描(LDCT)的数量,SDMC来自医疗保险提供者的使用和付款数据:医师和其他供应商的公共使用文件,以及从多个公共可用数据源中获得的州级因素。

2017年,每1000FFS受益人的LDCT利用密度中位数为3.32SDMC0.46,分别是2015年水平的24倍和13倍。从2015年到2017年,针对LCS收费的LDCT提供商数量从222家增加到3444家,SDMC20家增加到523家。LDCTSDMC的较高利用率往往集中在东北部和中西部州而不是西南部州。利用密度高的州并不是肺癌死亡率和/或吸烟率最高的州。

研究发现自医疗保险开始实施报销政策以来,LCS利用率呈稳定增长。美国各州的利用率及其增长各不相同,LDCTSDMC之间也有所不同,这表明LCS以及肺癌死亡率高和吸烟流行的州具有巨大的增长潜力。

原始出处:

Bian Liu. State-level variations in the utilization of lung cancer screening among fee-for-service Medicare beneficiaries: an analysis of the 2015-2017 Physician and Other Supplier data. Chest. 21 November 2019.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1929598, encodeId=df55192959867, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Sat Jan 11 15:38:00 CST 2020, time=2020-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051473, encodeId=f59120514e332, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Sun Apr 12 23:38:00 CST 2020, time=2020-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369712, encodeId=04b61369e123e, content=<a href='/topic/show?id=57b53481e9f' target=_blank style='color:#2F92EE;'>#医疗保险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34817, encryptionId=57b53481e9f, topicName=医疗保险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sun Dec 01 01:38:00 CST 2019, time=2019-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599611, encodeId=636d159961167, content=<a href='/topic/show?id=31992e25482' target=_blank style='color:#2F92EE;'>#保险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27254, encryptionId=31992e25482, topicName=保险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db9918732976, createdName=feifers, createdTime=Sun Dec 01 01:38:00 CST 2019, time=2019-12-01, status=1, ipAttribution=)]
    2020-01-11 Smile2680
  2. [GetPortalCommentsPageByObjectIdResponse(id=1929598, encodeId=df55192959867, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Sat Jan 11 15:38:00 CST 2020, time=2020-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051473, encodeId=f59120514e332, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Sun Apr 12 23:38:00 CST 2020, time=2020-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369712, encodeId=04b61369e123e, content=<a href='/topic/show?id=57b53481e9f' target=_blank style='color:#2F92EE;'>#医疗保险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34817, encryptionId=57b53481e9f, topicName=医疗保险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sun Dec 01 01:38:00 CST 2019, time=2019-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599611, encodeId=636d159961167, content=<a href='/topic/show?id=31992e25482' target=_blank style='color:#2F92EE;'>#保险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27254, encryptionId=31992e25482, topicName=保险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db9918732976, createdName=feifers, createdTime=Sun Dec 01 01:38:00 CST 2019, time=2019-12-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1929598, encodeId=df55192959867, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Sat Jan 11 15:38:00 CST 2020, time=2020-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051473, encodeId=f59120514e332, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Sun Apr 12 23:38:00 CST 2020, time=2020-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369712, encodeId=04b61369e123e, content=<a href='/topic/show?id=57b53481e9f' target=_blank style='color:#2F92EE;'>#医疗保险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34817, encryptionId=57b53481e9f, topicName=医疗保险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sun Dec 01 01:38:00 CST 2019, time=2019-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599611, encodeId=636d159961167, content=<a href='/topic/show?id=31992e25482' target=_blank style='color:#2F92EE;'>#保险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27254, encryptionId=31992e25482, topicName=保险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db9918732976, createdName=feifers, createdTime=Sun Dec 01 01:38:00 CST 2019, time=2019-12-01, status=1, ipAttribution=)]
    2019-12-01 xuyu
  4. [GetPortalCommentsPageByObjectIdResponse(id=1929598, encodeId=df55192959867, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Sat Jan 11 15:38:00 CST 2020, time=2020-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051473, encodeId=f59120514e332, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Sun Apr 12 23:38:00 CST 2020, time=2020-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369712, encodeId=04b61369e123e, content=<a href='/topic/show?id=57b53481e9f' target=_blank style='color:#2F92EE;'>#医疗保险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34817, encryptionId=57b53481e9f, topicName=医疗保险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sun Dec 01 01:38:00 CST 2019, time=2019-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599611, encodeId=636d159961167, content=<a href='/topic/show?id=31992e25482' target=_blank style='color:#2F92EE;'>#保险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27254, encryptionId=31992e25482, topicName=保险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db9918732976, createdName=feifers, createdTime=Sun Dec 01 01:38:00 CST 2019, time=2019-12-01, status=1, ipAttribution=)]
    2019-12-01 feifers

相关资讯

Chest:CT筛查检测到的小细胞肺癌特点及预后

LDCT的“早期检测”对SCLC预后没有影响。

中国肺癌低剂量螺旋CT筛查指南(2018年版)

肺癌是导致中国癌症死亡的首要原因。已有的研究证明低剂量螺旋CT在肺癌高危人群进行肺癌筛查能降低20%的肺癌死亡。本研究的目的是建立适合中国国情的肺癌筛查指南。本指南推荐的肺癌高危人群为:年龄50岁-74岁;吸烟20包/年,或者戒烟5年。参与肺癌LDCT筛查前,需要获得筛查者的知情同意。肺癌筛查需与健康教育结合,向患者宣传吸烟对健康的危害。因此,健康教育应该整合到肺癌筛查全过程,以便帮助患者戒烟。

NCCN临床实践指南:肺癌筛查(2019.V2)

2018年8月,美国国家综合癌症网络(NCCN)发布了肺癌筛查指南2019年第2版,指南主要内容包括: 指南更新摘要 风险评估 筛查结果 实性结节初始低剂量CT扫描 部分实性结节初始低剂量CT扫描 非实性结节初始低剂量CT扫描 随访或每年低剂量CT扫描新发结节 随访或每年低剂量CT扫描实性结节 随访或每年低剂量CT扫描部分实性结节 随访或每年低剂量CT扫描非实性结节 多种非实性结节 低剂量CT扫描

2018 ACR适宜性标准:肺癌筛查

2018年11月,美国放射学会(ACR)发布了肺癌筛查的影像学检查标准建议,肺癌仍是癌症死亡的主要原因,本文主要针对肺癌筛查的影像学检查提供指导建议,涉及低剂量CT筛查和肺癌筛查的年龄以及人群等。

Thorax:NELSON CT肺癌筛查研究随机轮次中持续存在的新结节

LDCT肺癌筛查中超过一半的新发低中危实性结节会消退。随访中,与体积阈值相结合的生长评估可被用于风险分层。

NCCN临床实践指南:肺癌筛查(2019.V1)

2018年6月,美国国家综合癌症网络(NCCN)发布了肺癌筛查指南2019年第1版,指南主要内容包括: 指南更新摘要 风险评估 筛查结果 实性结节初始低剂量CT扫描 部分实性结节初始低剂量CT扫描 非实性结节初始低剂量CT扫描 随访或每年低剂量CT扫描新发结节 随访或每年低剂量CT扫描实性结节 随访或每年低剂量CT扫描部分实性结节 随访或每年低剂量CT扫描非实性结节 多种非实性结节 低剂量CT扫描